-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Lowers Price Target to $12

Benzinga·02/27/2026 17:48:17
Listen to the news
Wells Fargo analyst Vik Chopra maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight and lowers the price target from $13 to $12.